Market Closed -
Oslo Bors
10:45:00 2024-05-03 am EDT
|
5-day change
|
1st Jan Change
|
0.1424
NOK
|
-1.66%
|
|
-5.32%
|
-48.78%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
1,461
|
1,487
|
2,810
|
1,794
|
662.3
|
556.6
|
556.6
|
-
|
Enterprise Value (EV)
1 |
1,100
|
1,234
|
2,089
|
1,358
|
511.8
|
591
|
627.5
|
840.5
|
P/E ratio
|
-7.42
x
|
-7.1
x
|
-9.39
x
|
-5.76
x
|
-2.19
x
|
-2.14
x
|
-1.97
x
|
-1.69
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
626
x
|
167
x
|
4,675
x
|
2,242
x
|
1,703
x
|
2,111
x
|
-
|
-
|
EV / Revenue
|
471
x
|
139
x
|
3,477
x
|
1,698
x
|
1,316
x
|
1,670
x
|
-
|
-
|
EV / EBITDA
|
-5.66
x
|
-6.06
x
|
-8.03
x
|
-4.34
x
|
-1.68
x
|
-3.08
x
|
-3.22
x
|
-3.75
x
|
EV / FCF
|
-5.89
x
|
-
|
-8.92
x
|
-4.45
x
|
-1.8
x
|
-1.78
x
|
-
|
-
|
FCF Yield
|
-17%
|
-
|
-11.2%
|
-22.5%
|
-55.7%
|
-56.2%
|
-
|
-
|
Price to Book
|
4.22
x
|
-
|
3.6
x
|
4.64
x
|
7.48
x
|
5.86
x
|
-20.2
x
|
-2.36
x
|
Nbr of stocks (in thousands)
|
54,711
|
61,077
|
87,260
|
88,455
|
88,661
|
3,908,712
|
3,908,712
|
-
|
Reference price
2 |
26.70
|
24.35
|
32.20
|
20.28
|
7.470
|
0.1424
|
0.1424
|
0.1424
|
Announcement Date
|
2/12/19
|
2/11/20
|
2/10/21
|
2/16/22
|
2/16/23
|
2/14/24
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
2.335
|
8.9
|
0.601
|
0.8
|
0.389
|
0.354
|
-
|
-
|
EBITDA
1 |
-194.3
|
-203.6
|
-260.4
|
-313.2
|
-304.8
|
-191.6
|
-194.8
|
-224.2
|
EBIT
1 |
-194.5
|
-204.4
|
-261.1
|
-314.5
|
-305.6
|
-191.8
|
-195.1
|
-224.6
|
Operating Margin
|
-8,331.43%
|
-2,296.63%
|
-43,442.76%
|
-39,312.5%
|
-78,569.41%
|
-54,186.16%
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-191.7
|
-199.3
|
-257
|
-309.4
|
-302.1
|
-190.4
|
-194.7
|
-233.7
|
Net income
1 |
-191.7
|
-199.3
|
-257
|
-309.4
|
-302.1
|
-190.4
|
-194.7
|
-233.7
|
Net margin
|
-8,209.85%
|
-2,239.08%
|
-42,766.89%
|
-38,670.5%
|
-77,666.32%
|
-53,785.59%
|
-
|
-
|
EPS
2 |
-3.600
|
-3.430
|
-3.430
|
-3.520
|
-3.410
|
-0.1300
|
-0.0724
|
-0.0841
|
Free Cash Flow
1 |
-186.9
|
-
|
-234.4
|
-305.3
|
-285
|
-241
|
-
|
-
|
FCF margin
|
-8,005.74%
|
-
|
-38,994.51%
|
-38,163.87%
|
-73,260.41%
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/12/19
|
2/11/20
|
2/10/21
|
2/16/22
|
2/16/23
|
2/14/24
|
-
|
-
|
Fiscal Period: December |
2019 S1
|
2020 S1
|
2021 Q2
|
2021 S1
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
8.682
|
-
|
-
|
-
|
-
|
0.8
|
-
|
-
|
-
|
-
|
0.389
|
-
|
-
|
-
|
0.354
|
-
|
-
|
-
|
-
|
-
|
EBITDA
1 |
-
|
-
|
-91.97
|
-
|
-71.08
|
-67.01
|
-78.25
|
-87.92
|
-
|
-62.29
|
-76.29
|
-72.42
|
-
|
-27.98
|
-43.44
|
-46.2
|
-48.28
|
-94.5
|
-51.9
|
-56.5
|
EBIT
1 |
-
|
-
|
-92.31
|
-175.7
|
-71.42
|
-67.3
|
-78.57
|
-88.2
|
-166.8
|
-62.43
|
-76.4
|
-72.42
|
-
|
-
|
-43.54
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-8,412.5%
|
-
|
-
|
-
|
-
|
-19,640.87%
|
-
|
-
|
-
|
-12,300.28%
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-97.1
|
-115.8
|
-88.86
|
-170.1
|
-70.5
|
-68.77
|
-81.07
|
-84.07
|
-165.1
|
-59.8
|
-77.19
|
-72
|
-
|
-27.93
|
-41.64
|
-45.1
|
-47.28
|
-92.3
|
-51.6
|
-57.6
|
Net income
1 |
-97.1
|
-115.8
|
-88.86
|
-170.1
|
-70.5
|
-68.77
|
-81.07
|
-84.07
|
-165.1
|
-59.8
|
-77.19
|
-72
|
-48.84
|
-27.93
|
-41.64
|
-45.1
|
-47.3
|
-92.3
|
-51.6
|
-57.6
|
Net margin
|
-1,118.38%
|
-
|
-
|
-
|
-
|
-8,595.75%
|
-
|
-
|
-
|
-
|
-19,842.93%
|
-
|
-
|
-
|
-11,761.3%
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-1.760
|
-1.590
|
-1.020
|
-1.940
|
-0.8000
|
-0.7800
|
-0.9200
|
-0.9500
|
-1.860
|
-
|
-0.8700
|
-
|
-0.1500
|
-0.0100
|
-0.0200
|
-0.0200
|
-0.0200
|
-0.0300
|
-0.0200
|
-0.0200
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/19/19
|
8/17/20
|
8/17/21
|
8/17/21
|
11/16/21
|
2/16/22
|
5/24/22
|
8/23/22
|
8/23/22
|
11/15/22
|
2/16/23
|
6/22/23
|
8/23/23
|
11/14/23
|
2/14/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
70.9
|
284
|
Net Cash position
1 |
360
|
254
|
720
|
436
|
151
|
156
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-0.3638
x
|
-1.266
x
|
Free Cash Flow
1 |
-187
|
-
|
-234
|
-305
|
-285
|
-241
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-55.8%
|
-
|
-57.8%
|
-58.7%
|
-128%
|
-176%
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-50.3%
|
-
|
-51%
|
-52.1%
|
-97.9%
|
-112%
|
-
|
-
|
Assets
1 |
381.5
|
-
|
504.3
|
594.2
|
308.5
|
170.5
|
-
|
-
|
Book Value Per Share
2 |
6.330
|
-
|
8.950
|
4.370
|
1.000
|
0.0500
|
-0.0100
|
-0.0600
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
0.23
|
-
|
0.07
|
-
|
0.3
|
0.31
|
0.33
|
0.35
|
Capex / Sales
|
9.76%
|
-
|
11.15%
|
-
|
76.86%
|
-
|
-
|
-
|
Announcement Date
|
2/12/19
|
2/11/20
|
2/10/21
|
2/16/22
|
2/16/23
|
2/14/24
|
-
|
-
|
Mean consensus UNDERPERFORM Last Close Price
0.1424
NOK Average target price
0.7667
NOK Spread / Average Target +438.39% Consensus |
1st Jan change
|
Capi.
|
---|
| -48.78% | 51.34M | | +8.96% | 105B | | -1.43% | 104B | | +4.40% | 22.94B | | -12.15% | 22.34B | | -4.36% | 19.25B | | -39.98% | 17.08B | | -10.04% | 16.96B | | +38.61% | 12.63B | | +313.59% | 8.49B |
Bio Therapeutic Drugs
|